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SUMMARY 
Studies were designed to determine whether pteroylmono- 
glutamate (PGA) at physiologic concentrations is transported 
across the small Intestine unaltered or is reduced and methyl¬ 
ated to the circulating folate form during absorption. ^H-PGA 
at varying concentrations was incubated on the mucosal side of 
rat jejunum placed between lucite chambers. Of the folate 
transferred to the serosal side, the percent identified as 
5-methyltetrahydrofolate (5-MTHF) by DEAE-Sephadex chromato¬ 
graphy was inversely related to the initial mucosal PGA concen¬ 
tration: at 7> 20 and 2000 nM, 46^, ~$2% and respectively 
was 5-MTHF. In contrast, at 20 nM the ileum converted <4^ to 
5-MTHF. IQ-^m methotrexate, a dihydrofolate (DHF) reductase 
inhibitor, markedly inhibited PGA conversion to 5-MTHF by the 
jejunum. DHF reductase activity was measured in homogenates 
of villus scrapings to determine if the difference in PGA con¬ 
version to 5-MTHF between jejunum and ileum might be explained 
by differences in this enzyme activity. The purity of the 
villus preparation was confirmed by a 5 fold increase in su- 
crase specific activity (S.A.) and a 20 fold decrease in thy¬ 
midine kinase S.A. compared to mucosal homogenates. A signifi¬ 
cant difference in DHF reductase S.A. in jejunal (0.105 ± 0.012 
jimole/hr/mg protein) compared to ileal villi (0.036 - 0.003) 
was found. These studies demonstrate that both the reduction 
and methylation of PGA to 5-MTHF and DHF reductase S.A. is 
greater in the jejunum than in the ileum. The initial reduction 
3 
* * 
*? 
of PGA to tetrahydrofolate by DHF reductase may be the rate 
limiting step. These results could explain previous studies 
which have failed to identify conversion of PGA at higher and 
less physiologic concentrations. 
« 
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INTRODUCTION 
The absorption of pteroylglutamic acid (folic acid, PGA) 
in man after oral administration has been demonstrated by stu¬ 
dies measuring plasma urine and fecal levels of folate deriva¬ 
tives1”"^. Clinical11-13 and experimental13"22 evidence favors 
the Jejunum as the primary site of folic acid absorption although 
one study21 in the rat finds no difference between jejunal and 
ileal PGA absorption. However, the mechanism by which PGA and 
its derivatives are transported across the small intestine is 
still uncertain. 
To understand the transport of folate*, it is useful to 
review qualitatively and quantitatively the distribution of 
folate derivatives in the diet and in the circulation. Analy¬ 
sis of food stuffs has revealed that between 80 and 90% of 
natural folates exist as polyglutamyl conjugates with unreduced 
and unconjugated PGA representing between 1 and 10$ of the to¬ 
tal dietary folate (500-700 pg)22^0. Moreover, the predomi¬ 
nant circulating and storage forms of folate are reduced forms, 
principally 5-methyltetrahydrofolate (5-MTHF)^. 
The data concerning the intestinal absorption of conju¬ 
gated folate (figure 6) suggests that the polyglutamate is 
quantitatively deconjugated before release into the circula¬ 
tion2, 51~35 although two studies^* 37 give evidence for the 
♦refers to all forms of folate 
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absorption of the intact heptaglutamate. In addition, the 
finding of negligible conjugase activity in the intestinal 
brush border^® has left the anatomical site of polyglutamate 
deconjugation in doubt. One study in rats2^ has elegantly de¬ 
monstrated by a variety of techniques that for 5-MTHF, intesti¬ 
nal transport is by a non-energy dependent non-saturable sys¬ 
tem. 
Despite our knowledge that 10% or less of dietary folate 
is PGA, most studies have dealt with the absorption of this 
compound alone1 » 23-27,4-5,46 since it is stable and available 
commercially. These investigations have presented conflicting 
data concerning the mechanism of PGA transfer across the intes¬ 
tine. Although several studies in rats16»21,23 and hamsters22*»2^ 
have demonstrated active transport as the process governing 
PGA absorption, other studies in the rat1^»20,26 an(j hamster2^ 
have not demonstrated active transport and have suggested that 
PGA is absorbed by passive diffusion. 
Following oral PGA administration, the plasma 5-MTHF level 
increases^* 39,4-5,4-6, Therefore PGA is converted to 5-MTHF at 
one or more sites between the point of ingestion and the peri- 
pheral circulation. Baker, ejt. al. ' suggested that folic acid 
was converted to 5-MTHF during transfer across the intestine, 
and studies in humans^ and with everted intestinal sacs2^ in 
the rat2*^ and hamster2^ are in agreement with this thesis. In 
addition, the finding of DHF reductase activity In the small 
intestine2*1 and its localization to the crypts of Lieberkuhn 
and the villus as determined by autoradiographic techniques2*2* 
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support those observations. However, in vivo perfusion studies 
of isolated intestinal segments in dogs35f experiments with 
everted intestinal sacs in rats20 and human studles^5>^6 ^n_ 
volving hepatic and umbilical vein catheterization give evidence 
that PGA crosses the intestine intact without metabolic conver¬ 
sion. 
The experiments failing to demonstrate reduction and 
methylation of PGA during absorption must be understood in 
light of the fact that conversion may have been masked by the 
pharmacologic doses of PGA used in these studies20» ^5,4-5>^6 
and that measures to protect reduced folates from light^ and 
aerobic condi tions20>35>45,4-6 appear not kave been adequately 
taken. 
It is the purpose of this study, utilizing recently 
developed chromatographic methods and the apparatus described 
by Schultz and Zalusky2^, to determine whether PGA at physiolo¬ 
gic concentrations is converted to other folate forms during 
transfer across the rat intestinal mucosa, and if so, to study 
a 
some of the characteristics of this conversion. 
7 
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MATERIALS AND METHODS 
MATERIALS 
Glucose oxidase, peroxidase, and o-dianisidine were pur¬ 
chased from Sigma, St. Louis, Missouri. MgCl2 was purchased 
from Mallinckrodt, St. Louis, Missouri. ATP, creatine phospho- 
kinase, creatine phosphate and unlabeled thymidine were pur¬ 
chased from Calbiochem, Los Angeles, California. Unlabeled 
folic acid (Polvite) and methotrexate (MTX) were obtained 
through the courtesy of Lederle, Pearl River, New York. 
2,5-Diphenyloxazole, p-Bis[2-(5-phenyloxazolyl)]-benzene and 
thymidine-2- ^0 (54 p.Ci/umole) were purchased from New England 
Nuclear, Boston, Massachusetts. ^H-PGA (33 Ci/mmole and 29 Ci/ 
mmole) was purchased from Amersham-Searle, Des Plaines, Illinois. 
METHODS 
I. Determination of mucosal to serosal folate transfer in the 
rat small intestine. 
oThe two lots of ^H-PGA labeled in the 3', 5' and 9 posi¬ 
tions of the molecule (figure 6) were purified by column chroma¬ 
tography on A-25 DEAE-Sephadex (Pharmacia). The purified lots 
had specific activities of 5.6 Ci/mmole and 45.8 Ci/mmole re¬ 
spectively, and were greater than 99% radiochemically pure. 
Mucosal to serosal transfer of ^H-PGA and its derivatives 
were determined under short circuited conditions using the 
methods and apparatus described by Schultz and Zalusky^. Flat 
sheets of rat jejunum or ileum from male albino Sprague-Dawley 
8 
#} 
rats weighing 300-350 grams were mounted between lucite cham¬ 
bers. Equimolar amounts of unlabeled PGA at varying concen¬ 
trations were placed on both the mucosal and serosal side of 
the chamber with approximately 3.0 pCi of -^H-PGA added to the 
mucosal, solution. After a 20 minute equilibration period, the 
rate of appearance of radiolabeled material in the serosal 
solution was determined by taking 1 ml aliquots from the sero¬ 
sal media at 20 minute intervals. The sample added to 10 ml of 
Bray's solution^ was counted in a Packard Tri-Carb 3-Channel 
liquid scintillation spectrometer for 10 minutes. In these 
studies, results were expressed in pmoles of folate transferred 
to the serosal solution per cm2 intestine per 100 minutes. All 
experiments were performed in the absence of light. Both sides 
of the tissue were bathed with identical solutions maintained 
at 37°C. and bubbled continously with 02-C02 (95:5» v/v). In 
all experiments, the composition of the buffer bathing solution 
in millimoles per liter was sodium chloride, 115; 'sodium bi¬ 
carbonate, 25; potassium phosphate, 5; magnesium chloride, 
I. 2;a calcium chloride, 1.2; ascorbic acid, 17} pH 7*4-. 
II. Identification of folate compounds by chromatography. 
At the end of 100 minutes, the serosal bathing solutions 
from two to three experiments were pooled and stored overnight 
in 3 M mercaptoethanol at 4°C. A similar procedure was followed 
for the mucosal bathing solutions. Folate compounds were chro- 
matographically identified using the method described by Nixon 
49 
and Bertino . The pooled serosal or mucosal samples containing 
folate markers were diluted to a salt concentration of 0.1 molar 
9 
*• 
and applied to a 0.9 x 27 cm column of A-25 DEAE-Sephadex 
equilibrated with 0.1 M phosphate buffer, pH 6.0, containing 
10 mM mercaptoethanol. Materials were eluted by phosphate 
buffer containing 10 mM mercaptoethanol, pH 6.0, the concen¬ 
tration of which was increased linearly from 0.1 M to 1.8 M. 
The final concentration of 1.8 M phosphate buffer was obtained 
after passage of 30 ml of eluting buffer. Non-radioactive 
markers of 5-MTHF, PGA and p-aminobenzoylglutamate (pABG) were 
added with the sample. Fractions of 2.5 ml were collected in 
the dark at 4°C. and monitored by ultraviolet absorbance spec¬ 
tra and by radioactivity. 0.5 ml aliquots per fraction were 
counted with the Packard Tri-Carb spectrometer in 15 ml of scin¬ 
tillation fluid containing 8.0 g of 2,5-Diphenyloxazole in 1 liter 
of absolute alcohol and 100 mg of p-Bis [2-(5-phenyloxazolyl)] - 
benzene in 2 liters of toluene. The compounds identified were 
quantitated in terms of pmoles of PGA or 5-MTHF transferred to 
the serosal solution per cm^ intestine per 100 min *by integrating 
the area under each peak in the chromatograph to determine the 
relative proportion of each compound transferred, and by combining 
this information with the total mucosal to serosal folate trans¬ 
fer obtained as described in section I. The average number of 
counts added to the column to identify the various folate com¬ 
pounds was between 25,000-30,000 cpm. At this level of activity, 
a 5-MTHF peak of at least of the total folate activity can 
be identified. Therefore, in those experiments in which a 5-MTHF 
peak was not observed, we are assuming that less than 5-MTHF 
10 
£ 
was present. Obviously, the correct amount of 5-MTHF is some¬ 
where between 0 and 4$. 
Ill. Preparation of rat small intestine for enzyme analysis 
and histology. 
Male albino Sprague-Pawley rats weighing 200-250 g placed 
under ether anesthesia had their small bowel excised and placed 
in cold 0.5 x 10"4M tris buffer with 10“4M thymidine*, pH 7.5 
(tris-thymidine buffer). The small intestine was divided into 
three equal parts of about 30 cm in length. The intestinal 
contents were removed from the proximal (Jejunal) and distal 
(ileal) segments by flushing with cold tris-thymidine buffer 
and the middle segment was discarded. The jejunum was divided 
into three equal parts of about 10 cm in length and two of the 
three segments selected at random were lightly scraped along the 
mucosa according to the method of Dietchy and Siperstein-^ to 
separate the intestinal villi from the cryps-muscle layer. Je- 
4 
junal villi scrapings were pooled and placed in 2-3 ml of tris- 
thymidine buffer. The third 10 cm segment underwent a more 
forceful scraping to separate total mucosa from the underlying 
*In preliminary experiments, it was found that the thymidin 
kinase assay could be performed on the intestinal homogenates 
only if the enzyme was stabilized by the presence of 10~4M thy¬ 
midine in tris buffer and if fresh supernatant fractions were 
utilized for the assay. 
f 
smooth muscle layer, after which the total mucosa was placed in 
3-5 ml of tris-thymidine buffer. The same procedures were fol¬ 
lowed for the 30 cm ileal segment. The histology of these in¬ 
testinal layers was determined on formalin fixed, hematoxylin 
and eosin and masson stained sections of each preparation 
(figure 9). The jejunal and ileal villi and total mucosa were 
each individually homogenized for 1-3 minutes with a glass 
motor-driven pestle in the initial volume of tris-thymidine 
buffer. The homogenates were then centrifuged for 15 minutes 
at 27,000 x g and the supernatant from each homogenate was 
divided into three aliquots. One aliquot was saved for the 
immediate determination of thymidine kinase activity and the 
other two were stored at -70°C. until used (usually within 
three days), for the determination of dihydrofolate reductase 
activity, sucrase activity and protein. 
Thymidine kinase assay: The thymidine kinase activity of the 
« 
fresh supernatant fraction of villi and total mucosa homogenates 
was determined using the assay of Chello and Jaffe^1 and the 
chromatographic separation of Furlong-^. The thymidine kinase 
activity is expressed as pmoles of thymidine-51-monophosphate 
formed per mg protein per 30 minutes. 
Dihydrofolate reductase assay; The dihydrofolate reductase 
activity of the supernatant fractions of villi and total mucosa 
homogenates was determined at pH 7.5 at 37°C. using the method 
of Bertino, et. al.^3. Activity is expressed as pmoles of di¬ 
hydrofolate reduced per hour per mg protein. 
Sucrase assay: The sucrase activity of the supernatant frac- 
12 

1 
tions of villi and total mucosa homogenates was determined 
according to the method of Dahlqvist-* . Activity is expressed 
as pg of glucose liberated per hour per mg protein. 
Protein determination: Protein concentrations of the super¬ 
natant fractions of villi and total mucosa homogenates were 
determined by the biuret method with bovine serum albumin as 
the standard. 
Statistics: Statistical significance was determined by the 
student t test^. 
13 

RESULTS 
The identification and quantitation of folate compounds absorbed 
by rat small intestine. 
The DEAE-Sephadex chromatographic identification of folate 
compounds in the serosal bathing solutions of rat jejunum incu¬ 
bated with 7 nM PGA, 20 nM PGA, 20nM PGA with 10“6M MTX, and 
with 2000 nM PGA and the ileum with 20 nM PGA are shown in 
figures 1-5. The folate transfer studies were combined with this 
chromatographic data to give the pmoles of 5-MTHF and PGA trans¬ 
ferred per cm^ intestine per 100 min as shown in table 1. The 
total folate transfer was found to be linearly related to muco¬ 
sal PGA concentration (table 1 and figure 8). 
It is seen that when the concentration of PGA in the muco¬ 
sal bathing solution incubating the jejunum is increased from 
7 nM to 2000 nM, the per cent of the total folate identified in 
the serosal bathing solution as 5-MTHF decreased from 46% to 
less than 4$6. Further, the presence of 10“^M MTX, a dihydro- 
fola'te reductase inhibitor, markedly decreased the appearance 
of 5-MTHF in the serosal solution when 20 nM PGA was present 
on the mucosal side of the jejunum. When 20 nM PGA was on the 
mucosal side of the ileum, less than 5-MTHF was identified. 
The pABG peak identified for the serosal media is the re¬ 
sult of oxidative breakdown of PGA and reduced folates occurring 
under the incubating conditions employed in these experiments 
(figure 7). The possibility of selective pABG uptake by in¬ 
testinal mucosa awaits further study. 
14 

Enzyme analysis of small Intestine. 
The thymidine kinase, DHF reductase and sucrase specific 
activities of the supernatant fractions of jejunal and ileal 
villi and total mucosa are shown In table 2. The purity of the 
villus preparation was confirmed by a five fold increase in 
sucrase specific activity and a twenty fold decrease in thymi¬ 
dine kinase specific activity when compared to total mucosa 
homogenates and by histology (figure 9). Although DHF reduc¬ 
tase specific activity was similar In proximal and distal to¬ 
tal mucosa homogenates (Pc0.2), a three fold increase in DHP 
reductase specific activity was found in jejunal villi compared 
to Ileal villi (PcO.OOl). On the other hand, the jejunal: ileal 
ratio of thymidine kinase and sucrase specific activities was 
Identical for both total mucosa homogenates and villi. 
15 

DISCUSSION 
These studies demonstrate that the reduction and methyl- 
ation of PGA to 5-MTHF occur in the rat small intestine and 
that this conversion is significantly greater in the jejunum 
than in the ileum. It is noted that in no chromatogram (fig¬ 
ures 1-5) were peaks of radioactivity identified which might 
prove to be intermediate compounds in the pathway of PGA's 
conversion to 5-MTHF. This suggests that the initial reduction 
of PGA to tetrahydrofdate (FH4) by DHF reductase may be the 
rate limiting step in this pathway (figure 7). However the 
absence of these peaks may indicate that the 17 mM ascorbate 
in the serosal bathing solution was not in sufficiently high 
concentration to protect these intermediate compounds from 
oxidation, and/or that chromatographing these intermediates 
in amounts smaller than the assay system was capable of identi¬ 
fying may have resulted in their presence being masked. 
That methotrexate, a competitive stoichiometric inhibitor^ 
of DHF reductase, markedly diminished the percent PGA converted 
to 5-MTHF by the rat jejunum (figure 5) suggested to us that 
the differences in PGA reduction and methylation to 5-MTHF be¬ 
tween jejunum and ileum might be explained by differences in 
DHF reductase activity in these two regions of small intestine. 
In experiments with supernatant fractions of total mucosa homo¬ 
genates from jejunum and ileum, the differences in DHF reductase 
activity was not statistically significant (Pc0.2). However, 
the crypt region within the mucosa of the small bowel, a region 
16 
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of active DNA57,58 and protein^?* 59 synthesis, might be ex¬ 
pected to contain this enzyme in sufficient activity to mask 
real differences in specific activity between jejunal and ileal 
villi, the tissue usually considered important in intestinal 
absorption. Villus homogenates prepared according to the me¬ 
thod of Dietchy and Siperstein^O did reveal a higher DHF reduc¬ 
tase specific activity in jejunal compared to ileal villi (P*=rO.001 ). 
This is in contrast to findings of an identical jejunal:ileal 
ratio for thymidine kinase and sucrase specific activities in 
both total mucosa homogenates and villi (table 2). 
The use of sucrase and thymidine kinase as enzyme markers 
to verify the purity of the villus preparation is based on the 
work of Van Genderen^0 and others^?*^1 >62^ dealt with se¬ 
quential biochemical analyses from villus to crypt in the in¬ 
testine of the rat and demonstrated villi:crypt ratios of 4.0 
and 0.02 for sucrase^ and thymidine kinase^ respectively. 
There is at least one study which by autoradiographic tech- 
44 
niques indirectly demonstrated DHF reductase activity in the 
villi of the proximal small bowel. Results of further experiments 
to determine if DHF reductase is localized to the microvilli of 
the brush border might suggest, as proposed by Crane^, whether or 
not a ''kinetic advantage" exists for the absorption of PGA simi¬ 
lar to that which may exist for disaccharide absorption, on 
the basis of specific membrane-substrate-enzyme organization 
at the level of the microvillus. It would also be interesting 
to determine whether DHF reductase in the highly specialized 
villus has the same properties as DHF reductase in the relatively 
17 
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* 
undifferentiated crypt cell. 
These results indicate that the transfer of PGA across 
the intestine is directly related to the mucosal PGA concen¬ 
tration (figure 8). However the percent PGA converted to 5- 
MTHF is not linearly related to PGA concentration: at 7 nM 
PGA, 46$ is methylated, but at 2000 nM less than 4$ can be 
identified as 5-MTHF in the serosal solution (table 1). This 
data can then be interpreted to indicate that PGA to 5-MTHF 
conversion requires a rate limiting step but that total PGA 
transfer does not take place in a saturable system (figure 8). 
One would like to speculate that the saturable process for PGA 
absorption observed by some investigators^, 21 * ^3-25 ^s re_ 
lated to this rate limiting step of PGA conversion to 5-MTHF. 
Therefore, what one finds in the serosal solution or pre- 
hepatic blood sample is dependent upon the concentration of PGA 
used in the mucosal incubating media, the surface area and time 
available for absorption, the quantity of folate in the sample 
to be analyzed and upon the sensitivity of the assay method em¬ 
ployed. Previous experiments in the field which appeared to be 
utilizing quantities of PGA greater than 100 nM20*55,45,46 
would therefore not be expected to identify a significant per¬ 
centage of 5-MTHF during absorption. Smith, Matty and Blair, 
in studies with everted intestinal sacs from rats20 incubated 
with 10-7 to 10~^M PGA, did report a "minor radioactive compo¬ 
nent" with their chromatographic assay system which cochromato¬ 
graphed with both 5-formyltetrahydropteroylglutamic acid and 5- 
MTHF markers. Also, the possibility that the measures taken in 
18 

these studies to protect reduced folates from light-^ and 
aerobic conditions20, ^5»^5» 4-6 were not optimal may have con¬ 
tributed to the difficulty encountered by these workers in 
identifying absorbed 5-MTHP. Both Strum, et. al. 0 and Cohen25, 
having used everted intestinal sacs from rats and hamsters re¬ 
spectively, found conversion of PGA to 5-MTHP during absorption. 
However, they did not study the characteristics of this conversion. 
The mucosa to serosa transfer data for jejunum and ileum 
(table 1), derived from only two to three pooled experiments 
per study, does not have statistical validity for any conclusion 
to be drawn regarding a preferential site for folate absorption. 
Past clinical11”1'’ and experimental1 20 research favors the 
jejunum as the primary site of folic acid absorption although 
one study in the rat21 finds no difference between jejunal and 
ileal PGA absorption. 
The recent observation^ that the small intestine of the 
rat is the only organ which lacks the 5-methyltetrahydrofolate- 
homocysteine methyltransferase enzyme for the conversion of 
homocysteine to methionine may indicate that in methionine meta¬ 
bolism there is a shunting of 5-MTHP, the predominant circulating 
and storage form of folate^, via the blood stream to the liver, 
kidney, adrenals, testes, pancreas and brain, where in all these 
organs good specific activity for this enzyme has been found^. 
If other enzymes related to folate utilization are found to be 
lacking in the small intestine, it may suggest that the small 
intestine is an effective '‘scavenger” of dietary folate for pre¬ 
ferential use elsewhere in the body. 
19 
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Reports of a congenital isolated defect for folate absorp 
tion in man 0,0' offer a good opportunity for further elucida¬ 
tion of the specific uptake mechanisms for PGA by the mucosal 
cell. 
20 

LEGENDS 
Figure 1 
Figure 2 
Figure 3 
Figure 4 
Chromatographic identification on DEAE-Sephadex of 
folate compounds found in the serosal bathing solu¬ 
tion of rat jejunum mounted between lucite chambers 
and incubated with 7 nM PGA in the mucosal and sero¬ 
sal solutions with ^H-PGA in the mucosal solution. 
Results of three pooled experiments. Radioactivity 
was identified in the 273, 280 and 289 mji peaks 
which cochromatographs with unlabeled pABG, PGA and 
5-MTHF. pABG, PGA and 5-MTHF were added to the col¬ 
umn as markers. 
Chromatographic identification on DEAE-Sephadex of 
folate compounds found in the serosal bathing solu¬ 
tion of rat jejunum incubated with 20 nM PGA. Re¬ 
sults of two pooled experiments. Further details 
are presented in figure 1 and in the text. 
Chromatographic identification on DEAE-Sephadex of 
folate compounds found in the serosal bathing solu¬ 
tion of rat jejunum incubated with 20 nM PGA and 10"^M 
methotrexate. Results of two pooled experiments. 
Furtner details are presented in figure 1 and in the 
text. 
. Chromatographic identification on DEAE-Sephadex of 
folate compounds found in the serosal bathing solu¬ 
tion of rat jejunum incubated with 2000 nM PGA. Re¬ 
sults of two pooled experiments. Further details 

are presented in figure 1 and in the text 
Figure 5 
Figure 6 
Figure 7 
Figure 8 
Figure 9 
Chromatographic identification on DEAE-Sephadex of 
folate compounds found in the serosal bathing solu¬ 
tion of rat ileum incubated with 20 nM PGA. Results 
of two pooled experiments. Further details are pre¬ 
sented in figure 1 and in the text. 
The structure of pteroic acid, folic acid and folic 
acid polyglutamates. Glutamic acid residues are 
gamma carboxy linked. Modified from Krumdieck and 
Baugh^S, 
The pathway for the reduction and methylation of 
folic acid to 5-methyltetrahydrofolic acid. 
Graphic representation of data from table 1 demon¬ 
strating the transfer of total folate (-) and 
5-MTHF (-) from the mucosal to the sferosal solu¬ 
tion with increasing PGA 
L Jmucosal 
Histologic demonstration of villus scrapings pre¬ 
pared as described in the text. Only pure villi 
were identified in the villus scrapings. 
22 
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FIGURE 7 
Folic Acid oxidation p^BG + pterin 
| (DHF reductase) 
FH2 
| (DHF reductase) 
FH4 option pABG + pterin 
| (THF synthetase) 
10-Formyl FH4 
1 (cyclohydrolase) 
5,10-Methenyl F% 
serine glycine 
j (Methylene FH4 dehydrogenase) 
5,10-Methylene FH4 
(5,10-Methylene THF reductase) 
5-Methyl F% 
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Figure 9. 
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